Statines et effets indésirables musculaires : Cardilogie préventive = Statins and muscular side-effectsRODONDI, Nicolas; BROSTEAUX, Christine; RUIZ, Juan et al.Revue médicale suisse. 2010, Vol 6, Num 239, issn 1660-9379, 510-517 [6 p.]Article

IV thrombolysis and statinsENGELTER, S. T; SOINNE, L; ZINI, A et al.Neurology. 2011, Vol 77, Num 9, pp 888-895, issn 0028-3878, 8 p.Article

Statins in dermatologyJOWKAR, Farideh; MOHAMMAD REZA NAMAZI.International journal of dermatology. 2010, Vol 49, Num 11, pp 1235-1243, issn 0011-9059, 9 p.Article

The Acute (Cerebro)Vascular Effects of StatinsPRINZ, Vincent; ENDRES, Matthias.Anesthesia and analgesia. 2009, Vol 109, Num 2, pp 572-584, issn 0003-2999, 13 p.Article

A peri-operative statin update for non-cardiac surgery. Part II: Statin therapy for vascular surgery and peri-operative statin trial designBICCARD, B. M.Anaesthesia. 2008, Vol 63, Num 2, pp 162-171, issn 0003-2409, 10 p.Article

Consequences of Succinylcholine Administration to Patients Using StatinsTURAN, Alparslan; MENDOZA, Maria L; GUPTA, Shipra et al.Anesthesiology (Philadelphia). 2011, Vol 115, Num 1, pp 28-35, issn 0003-3022, 8 p.Article

Statin induced myopathySATHASIVAM, Sivakumar; LECKY, Bryan.BMJ. British medical journal (International ed.). 2008, Vol 337, Num 7679, pp 1159-1162, issn 0959-8146, 4 p.Article

Statin Therapy within the Perioperative PeriodLE MANACH, Yannick; CORIAT, Pierre; COLLARD, Charles D et al.Anesthesiology (Philadelphia). 2008, Vol 108, Num 6, pp 1141-1146, issn 0003-3022, 6 p.Article

The THRombolysis and STatins (THRaST) studyCAPPELLARI, Manuel; BOVI, Paolo; TASSINARI, Tiziana et al.Neurology. 2013, Vol 80, Num 7, pp 655-661, issn 0028-3878, 7 p.Article

Exploiting a Physiological Regulator to Improve the Efficacy and Safety of StatinsGILL, Saloni; BROWN, Andrew J.Cardiovascular drugs and therapy. 2011, Vol 25, Num 2, pp 183-185, issn 0920-3206, 3 p.Article

What is a relevant statin concentration in cell experiments claiming pleiotropic effects?BJÖRKHEM-BERGMAN, Linda; LINDH, Jonatan D; BERGMAN, Peter et al.British journal of clinical pharmacology. 2011, Vol 72, Num 1, pp 164-165, issn 0306-5251, 2 p.Article

Outcomes after thrombolysis in AIS according to prior statin use: A registry and reviewMESEGUER, Elena; MAZIGHI, Mikael; OLIVOT, Jean-Marc et al.Neurology. 2012, Vol 79, Num 17, pp 1817-1823, issn 0028-3878, 7 p.Article

Relation of Statin Nonadherence and Treatment IntensificationPITTMAN, Donald G; FENTON, Cynthia; CHEN, William et al.The American journal of cardiology. 2012, Vol 110, Num 10, pp 1459-1463, issn 0002-9149, 5 p.Article

Efficacité et efficience des hypolipémiants Une analyse centrée sur les statinesAngéiologie (Paris). 2010, Vol 62, Num 4, pp 24-31, issn 0003-3049, 8 p.Article

Do the cholesterol-lowering properties of statins affect cancer risk?SOLOMON, Keith R; FREEMAN, Michael R.Trends in endocrinology and metabolism. 2008, Vol 19, Num 4, pp 113-121, issn 1043-2760, 9 p.Article

Rarity of Anti―3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Antibodies in Statin Users, Including Those With Self-Limited Musculoskeletal Side EffectsMAMMEN, Andrew L; PAK, Katherine; WILLIAMS, Emma K et al.Arthritis care and research. 2012, Vol 64, Num 2, pp 269-272, issn 0893-7524, 4 p.Article

A Current Approach to Statin IntoleranceTOMPKINS, R; SCHWARTZBARD, A; GIANOS, E et al.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 1, pp 74-80, issn 0009-9236, 7 p.Article

The Controversies of Statin Therapy: Weighing the EvidenceWOUTER JUKEMA, J; CANNON, Christopher P; DE CRAEN, Anton J. M et al.Journal of the American College of Cardiology. 2012, Vol 60, Num 10, pp 875-881, issn 0735-1097, 7 p.Article

Statins as Potential Antimalarial Drugs : Low Relative Potency and Lack of Synergy with Conventional Antimalarial DrugsWONG, Rina P. M; DAVIS, Timothy M. E.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2212-2214, issn 0066-4804, 3 p.Article

Statins attenuate polymethylmethacrylate-mediated monocyte activationLAING, Alan J; DILLON, John P; MULHALL, Kevin J et al.Acta orthopaedica (Print). 2008, Vol 79, Num 1, pp 134-140, issn 1745-3674, 7 p.Article

Impact of Patient and Plan Design Factors on Switching to Preferred Statin TherapyCOX, Emily R; KULKARNI, Amit; HENDERSON, Rochelle et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 12, pp 1946-1953, issn 1060-0280, 8 p.Article

Statins for the primary prevention of cardiovascular diseaseEBRAHIM, Shah; TAYLOR, Fiona C; BRINDLE, Peter et al.BMJ (Overseas and retired doctors ed.). 2014, Vol 348, Num 7944, pp 32-35, issn 1759-2151, 4 p.Article

Intermittent Nondaily Dosing Strategies in Patients with Previous Statin-Induced MyopathyKEATING, Alyssa J; BOVA CAMPBELL, Kristen; GUYTON, John R et al.The Annals of pharmacotherapy. 2013, Vol 47, Num 3, pp 398-404, issn 1060-0280, 7 p.Article

Statins as Antithrombotic DrugsVIOLI, Francesco; CALVIERI, Camilla; FERRO, Domenico et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 2, pp 251-257, issn 0009-7322, 7 p.Article

Effets cliniques à court terme des statines initiées avant une intervention = Short-term clinical effects of periprocedural statin therapyAMBROSI, Pierre.La Presse médicale (1983). 2013, Vol 42, Num 3, pp 261-268, issn 0755-4982, 8 p.Article